KSI-3716 - CAS# 1151813-61-4 Catalog No.:M12760-2 COC1=CC2CN(CCC3C=CC(=CC=3)NC(=O)C3=CC(OC)=C(C=C3NC(=O)C3=CC4=CC=CC=C4N=C3)OC)CCC=2C=C1OC

COC1=CC2CN(CCC3C=CC(=CC=3)NC(=O)C3=CC(OC)=C(C=C3NC(=O)C3=CC4=CC=CC=C4N=C3)OC)CCC=2C=C1OC

Results reveal a significant delay of paralysis upon 18α-Glycyrrhetinic acid treatment

InChiKey: UZWDCWONPYILKI-UHFFFAOYSA-N

InChiKey: CCRXMHCQWYVXTE-HMRSNRLKSA-N

2009 Feb 19

KSI-3716 - CAS# 1151813-61-4 Catalog No.:M12760-2 COC1=CC2CN(CCC3C=CC(=CC=3)NC(=O)C3=CC(OC)=C(C=C3NC(=O)C3=CC4=CC=CC=C4N=C3)OC)CCC=2C=C1OCKSI 3716 is a potent c Myc inhibitor that blocks c MYC MAX binding to target gene promoters. KSI 3716 is an effective intravesical chemotherapy agent for bladder cancer. Product information CAS Number: 1151813 61 4 Molecular Weight: 426. 09 Formula: C17H11BrCl2N2O2 Chemical Name: 3 acetyl 8 bromo 5 chloro 2 [(4 chlorophenyl)amino] 1, 4 dihydroquinolin 4 one Smiles: CC(=O)C1=C(NC2=C(C(Cl)=CC=C2Br)C1=O)NC1C=CC(Cl)=CC=1 InChiKey: URUPDOIKTMCJNA